Post-Transplantation Day +100 Minimal Residual Disease Detection Rather Than Mixed Chimerism Predicts Relapses after Allogeneic Stem Cell Transplantation for Intermediate-Risk Acute Myelogenous Leukemia Patients Undergoing Transplantation in Complete Remission
- Resource Type
- Article
- Source
- In
Transplantation and Cellular Therapy July 2022 28(7):374-374 - Subject
- Language
- ISSN
- 2666-6367